Results 111 to 120 of about 344,007 (291)

Melanocortins and Their Potential for the Treatment, Prevention and Amelioration of Complications of Diabetes

Diabetology
Diabetes mellitus (type I and II) is an advancing global health problem, concerningly increasing in prevalence in most of the developed and developing world.
Gardner N. Robinson, Raelene J. Pickering   +1 more
doaj   +1 more source

Diabetic Retinopathy: A Position Statement by the American Diabetes Association

Diabetes Care, 2017
Diabetic retinopathy diagnostic assessment and treatment options have improved dramatically since the 2002 American Diabetes Association Position Statement (1).
Sharon D. Solomon, E. Chew, E. Duh, L. Sobrin, Jennifer K. Sun, B. VanderBeek, C. Wykoff, T. W. Gardner   +7 more
semanticscholar   +1 more source

Retinopathy online challenge: automatic detection of microaneurysms in digital color fundus photographs. [PDF]

, 2010
Contains fulltext : 89373.pdf (Publisher’s version ) (Open Access)The detection of microaneurysms in digital color fundus photographs is a critical first step in automated screening for diabetic retinopathy (DR), a common complication ...
Li, Q., Hiroshi Fujita, Karray, F., Mizutani, A, Hatanaka, Y, Abramoff, Michael D., Jane You, Roberto Hornero Member, Chisako Muramatsu, Quellec, G., Cochener, B, Cazuguel, G., Atsushi Mizutani, Hornero, R., Roux, Christian, van Ginneken, Bram, Cazuguel, Guy, You, Jane, Cochener, Beatrice, Quellec, Gwenole, Van Ginneken, B, Muramatsu, C., Lamard, M., Michael D. Abràmoff, Karray, Fakhri, Bob Zhang, Niemeijer, M., Fujita, H, Hatanaka, Y., Garc?a, M, Abramoff, M.D., Michael J. Cree Senior Member, Wu, X., S?nchez, CI, Roux, C., Quellec, G, Mizutani, A., Hatanaka, Yuji, Lamard, M, Hornero, Roberto, Niemeijer, M, Mayo, Augustin, Yuji Hatanaka, Christian Roux, Sanchez, Clara I., Hornero, R, You, J, Mayo, Agustin, Li, Qin, Zhang, Bob, Garcia, M., Fakhri Karray, Fujita, H., Cree, M.J., Lamard, Mathieu, Wu, Xiangqian, Zhang, B., García, María, Clara I. Sánchez Member, Sanchez, C.I., Fujita, Hiroshi, Niemeijer, Meindert, Guy Cazuguel Member, Meindert Niemeijer, Senior Member, Abr?moff, MD, Roux, C, Karray, F, Wu, Q, Mayo, A, Mathieu Lamard, Mayo, A., Mizutani, Atsushi, Bram Van Ginneken, Muramatsu, C, Muramatsu, Chisako, You, J., Cree, MJ, Cochener, B., Qin Li, Zhang, B, Xiangqian Wu, Student Member, Ginneken, B. van, Cazuguel, G, Cree, Michael J., Li, Q   +86 more
core   +2 more sources

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Role of Inflammation in Diabetic Retinopathy

International Journal of Molecular Sciences, 2018
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is
A. Rübsam, Sonia J. Parikh, P. Fort
semanticscholar   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Pentoxifylline dose finding trial in preterm neonates with suspected late onset sepsis (PTX‐trial)

British Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study (PTX‐trial) is to determine the optimal dose of pentoxifylline (PTX) in preterm neonates (gestational age < 30 weeks) with (suspected) late onset sepsis (LONS). Methods The PTX‐trial is a prospective multicentre open‐label sequential dose‐optimization study with an adapted continual reassessment method.
Serife Kurul, H. Rob Taal, Jan Mazela, Ryszard Lauterbach, Irwin K. M. Reiss, Karel Allegaert, Robert B. Flint, Sinno H. P. Simons   +7 more
wiley   +1 more source

Retinopathy of prematurity: a review of risk factors and their clinical significance.

Survey of ophthalmology, 2018
Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that affects premature infants. Despite improvements in neonatal care and management guidelines, ROP remains a leading cause of childhood blindness worldwide.
S. J. Kim, Alexander D. Port, Ryan Swan, J. Campbell, R. P. Chan, Michael F. Chiang   +5 more
semanticscholar   +1 more source

Urogenital Infection Risk Associated With SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Target Trial Emulation

Clinical Pharmacology &Therapeutics, EarlyView.
Although sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are recommended for patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), concerns regarding urogenital infections persist. Therefore, we evaluated the risk of urinary tract infection (UTI) and genital tract infection (GTI) after SGLT2i initiation in this population ...
Young‐Mi Ah, Junsung Nam, Jung Wook Youn, Yun Mi Yu, Soyoung Kang   +4 more
wiley   +1 more source

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss

Eye and Vision, 2015
Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285 million people with diabetes mellitus worldwide, approximately one third have signs of DR and of these, a further one third of DR is vision-threatening DR ...
Ryan Lee, T. Wong, C. Sabanayagam
semanticscholar   +1 more source